Senseonics prices $50M public offering of 100M shares at $0.50; Abbott to purchase $25M in concurrent private placement

Senseonics Holdings, Inc.

Public offering of 100M shares priced at $0.50/share, with 15M-share overallotment option to underwriters.
Net proceeds expected ~$45.4M ($52.45M if overallotment exercised); closing May 19, 2025.
Abbott Laboratories will purchase $25M of common stock at $0.50/share in a separate private placement closing May 21, 2025.
Proceeds to fund Eversense 365 launch, pipeline development, and working capital.
TD Cowen and Barclays lead as joint book-running managers; RBC Capital Markets and Lake Street as bookrunners.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.